mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.03 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |